Stay updated on Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page.

Latest updates to the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page
- Check4 days agoChange DetectedTwo keywords were added to the study's keyword list: Small cell lung carcinoma and Cutaneous neuroendocrine carcinoma.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded Hepatocellular carcinoma as a keyword and updated the site revision to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded the disease keyword Gastric cancer and updated the page revision from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check61 days agoChange DetectedFooter revision label updated from v3.4.0 to v3.4.1; no changes to study data or page navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check68 days agoChange DetectedUI/text updates include a glossary toggle, updated QC-related labels, and new footer/version information (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0), with no changes to the core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page.